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Abstract 
A study to assess the resolution of urinary tract 
morbidity due to Schistosoma haematobium was con- 
ducted on 2 cohorts of schoolchildren attending 
neighbouring schools in Rilombero District, southern 
Tanzania. Schoolchildren were screened for-S. haema- 
tobium infection usine the standard World Health 
Organization filtratioi technioue and subsequently 
examined for urinary tract pathology using a portable 
3.0 MHz sector scanner (Siemens Sonoline 1300). 
Treatment with praziquantkl was given to all infected 
children. Children with observed urinary tract pathol- 
ogy received either 20 (x=52) or 40 (n=79) mg/kg 
body weight and were sonographically re-examined 
one, 2,3 and 6 months following treatment. Geomet- 
ric mean outputs of 21 and 19 eggs/ml of urine were 
detected in the 2 cohorts before treatment. Urinary 
tract pathology correlated positively with egg output 
(x2, P=O.O2) and microhaematuria (P=O~OOOl). 
Bladder (wall irregularities and polyps) and kidney 
(congestive changes) pathologies were found in 81% 
and 36%, respectively, of the group that received 
20 mg/kg of praziquantel, and in 78% and 46% of the 
group that received 40 mg/kg. Six months after 
treatment, 90*4% and 88.0% parasitological cure rates 
were obtained using 20 or 40 mg praziquanteYkg 
body weight. The respective pathology clearances 
were 88% and 91%. 20 mg/kg of praziquantel was as 
effective with regard to cure rates and reversibility of 
morbidity as 40 mg/kg. 
Introduction 
Reduction of morbidity is the immediate aim of the 
elobal strateev to control schistosomiasis (WHO, 
i%). Pub&d reports of methods to diagnose 
Schistosoma k ematobium infection and to measure the 
effect of control measures (BRINKMANN et al., 1988) 
rely on laboratory investigations rather than on direct 
assessment of pathology. Infection with S. haemato- 
bium causes upper and lower urinary tract lesions. 
Intravenous pyelography (FORSYTH, 1965), cystos- 
copy and computerized tomography (AISEN, 1983) 
have been used in the past to detect such lesions, but 
the invasive nature of such investigations., which must 
be confined to hospital settings, made it difficult to 
carry out longitudinal studies (MACDONALD et al., 
1968). 
Using ultrasound to assess urinary tract lesions 
permits the investigation of affected populations at 
community level (DEG~MONT et al., 1985). The 
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efficiency of ultrasound in detecting lesions has been 
demonstrated in comparison with intravenous 
pyelography and cystoscopy (BURKI et al., 1986). 
Reports on the evolution of obstructive uropathy after 
treatment have recently been published (DOEHRING et 
al., 1985; KING et al., 1988), but no detailed 
foi~~5-u~ of pathology clearance has yet been pre- 
Recent work suggests that morbidity control may 
be achieved by lower dosages of praziquantel than 
those currently recommended (WILKINS & MOORE, 
1987; TAYLOR et al., 1988). Because of a proposal to 
treat all oositive schoolchildren in the Kilombero 
District, south-east T anzania, we tested the econo- 
mical regimen of administering 20 mg/kg body 
weight doses of praziquantel. 
Morbidity control strategies require a careful moni- 
toring of direct and indirect morbidity indicators in 
order to determine treatment and retreatment cycles 
in different endemic settings. Considering this prior- 
itv in schistosomiasis control, this study was aimed at 
following the evolution over 6 months of uropathy 
related to S. haematobium followinn 2 different 
regimens of praziquantel using ultrasouid as a tool for 
direct detection of morbidity. 
Materials and Methods 
S&y area 
The study was carried out in a rural area of 
south-east Tanzania from March to Seotember 1986 
and from February to August 1988 with-pupils from 2 
neighbouring schools, Kibaoni and Milola. S. haema- 
tobium is endemic in the area and has been investi- 
gated previously (ZUMSTEIN, 1983). 
Study population 
202 pupils aged 7 to 20 years (mean 12.6) entered 
the study from Milola school and 236 pupils aged 8 to 
17 years (mean 12.4) from Ribaoni school. The study 
was aooroved bv the Tanzam ‘a Medical Research 
CounGi (UTAFITI) and informed consent was 
obtained locally at the schools from pupils, their 
parents and teachers. The latter participated actively 
in the health education during the surveys. 
Laboratorv methods 
Filtrations of 10 ml of urine per child were done on 
5 consecutive davs between 1000 and 1330 h. usine 
Nuclepore membranes (12 urn) (ZUMSTEIN, -1983r 
The urine was examined for microhaematuria, pro- 
tein&a and leucocyturia with Combur-9 reagent 
strips (Boehringer). Level of infection was estimated 
for each individual by the maximum egg output of his 
or her 5 daily urine samples. 
257 children (117 at Milola and 140 at Kibaoni 
schools) with positive egg counts were re-examined 
regularly until 6 months after treatment. 
Saography 
A brief clinical examination was carried out in all 
children and the urine was checked for macrohaema- 
turia. All children underwent a comprehensive ultra- 
sound examination of the urinary tract. A Siemens 
3-O MHz sector scanner (Sonoline 1300) was used, 
powered by a portable generator. Pupils were ex- 
amined in the supine position. Congestive changes of 
the kidneys were-recorded according to ELLENB~GEN 
(1978‘1 with sliaht modifications: fissures of both left 
and ~Aght kidneys were considered normal to mini- 
mize any possible interpretation bias at low pathology 
level. Pathology was recorded as mild congestion, 
moderate congestion, or severe congestion with hyd- 
ronephrosis. Ureters were checked for congestion. All 
children with congestive changes were asked to empty 
their bladders and were re-examined to prevent a 
wrong interpretation of congestion due to a full 
bladder (MORIN 81 BAKER, 1979). Other kidney 
pathology (blurred central echo complex) was not 
included in the evaluation. The internretation of the 
bladder wall structure was made according to its 
surface regularity, thickness and tumors. Thickness 
was measured at the back wall and recorded as 
pathological when >5 mm (BURKI et al., 1986). Any 
calcifications were recorded. 
Treatment and followup 
Pupils at the two schools were treated with 
praxiquantel at a single dose of 40 mg/kg and 
20 mg/kg respectively. Due to operational reasons 
there was no within-school randomization for the 2 
doses of praxiquantel. The treatment was adminis- 
tered during the Season of low transmission when 
small numbers of infected snails are found (SUTER, 
1986). 
124 infected pupils with pathology were re-ex- 
amined after treatment. The 72 nunils from Milola 
school (40 mg group) underwen‘t further scanning 
after one, 2 and 6 months, and the 52 pupils from 
Kibaoni school (20 mg group) were rescanned after 3 
and 6 months. We did not include a non-treated 
control group for ethical reasons. 
Stutistical an&.& 
Geometric mean of (x+1) eggs per 10 ml of urine 
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was used. Wherever appropriate, the x2 test, t-test, 
analysis of covariance (ANCOVA) or regression were 
applied for statistical analysis. 
Results 
The overall nrevalence of S. haematobium infections 
at Milola (n=202) and Kibaoni (n=236) schools was 
64.9% (95% confidence interval lCI1 58.3-71.5) and 
59.3% (95% CI 53.3-65.5). The over& pathology rate 
was 47.5% (95% CI 406-54.4) and 41.1% (95% CI 
34-8-47.4). Analysis of covariance showed that 
natholoav was wsitivelv associated with aae (F=5.4. 
p=O-Oq but not with sex (F=O.5, PgO.5). The 
laboratory follow-up investigations revealed no differ- 
ence in infection, intensity or clearance rates between 
boys and girls. 
117 children from Milola school and 140 from 
Kibaoni school were admitted to the study in order to 
evaluate the efficacy of a reduced dosage (20 mg/kg) 
of praxiouantel. The me- and post-treatment geomet- 
ric- mean egg outputs for the treatment groups are 
listed in Table 1. No sianificant difference was 
observed between the 2 trearment groups. Parasitolo- 
gical clearance rates are shown in Table 2. 
Seventy-two and 52 pupils with uropathy were 
followed sonographically at Milola (40 mg group) and 
Kibaoni (20 mg group) schools for a period of 6 
months after treatment. Bladder pathology was found 
initially in 81% of the group who received 20 mg/kg 
of praxiquantel and in 78% of the 40 mg/kg group. 
Congestive changes were found in 36% and 46% of the 
kidneys. Moderate to severe congestion and hyd- 
ronenhrosis were recorded in 3% and 16% of all 
kidneys. Bladder pathology was not present in 3 
pupils (84%) with moderate congestion. In one of 
these cases, the congestion resolved within 2 months 
after chemotherapy. Pathology of the left and right 
kidneys was recorded in 38% and 33% respectively in 
the 20 mg/kg group, and in 52% and 42% in the 
40 mg/kg group. 
Bladder and kidney pathologv correlated positively 
with egg output @‘<0.02) -and microhaematuria 
(P<O*OOl) in both erou~s. Patholoaical chances did 
not differ (P=O*2) ii children with heavy (>liio eggs 
per 10 ml of urine) and light infections (<lOO eggs). 
The evolution of urinary tract lesions is shown in 
Fies 1 and 2. The remession curves indicate that 
blidder pathology cle&ance was similar in both 
treatment groups, but that the clearance of kidney 
pathology tended to be slower in the first 3 months in 
Table 1. Geometric mean egg outputs before and after treatment with two dosages of praziquantel 
Dosage Number of 
Geometric mean egg output at 
months after treatment 
b&kg) children 0 1 3 6 
All children zii 140 21 1 1 1 
117 19 1 - 1 
Light infections” ii 107 10 1 1 1 
90 9 1 1 
Heavy infectionsb ii :: 230 : 2 1 
215 1 
“<lo0 eggs/l0 ml urine. 
b>lOO eggs/l0 ml urine. 
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Table 2. Parasitological clearance rates after treatment with two dosages of praziquantel 
Clearance ratesb at 
Dosage Number of months after treatment 
@wzW children 1 3 6 
All children 20 140 98.0 90.0 90-O 
40 117 80.0 - 88.0 
Standard error” 
Significance P<GO5 As’ 
Light infections’ 2 107 99.0 91.0 94.0 
90 86.0 - 91.0 
Standard errors 
Significance P&l is8 
Heavy infectionsd 2 ::: 94.0 87.0 79.0 
63.0 - 78.0 
Standard erroP 10.2 10.7 
Significance P<O*Ol NS 
‘Standard errors and significance (x2) refer to differences between results at the 2 dosage levels. 
bPercentage reduction at the months indicated; -=not examined. 
‘<lOO eggs/l0 ml urine. 
dalOO eggs/l0 ml urine. 
Table 3. Clearance rates of bladder pathology following treatment with different praziquantel dosages 
Dosage Number of Months after treatment’ 
Pathologya bWk~ cases 1 2 3 6 
Overall pathology 2 42 
27 50 
93 98 
62 - 95 
Standard errorb 3.5 




Standard errorb 21.1 




Standard errorb 46.3 
Irregular and 20 60 
thickened wall 40 2 17 29 ;: 
Standard errorb 10.2 
Calcifications 
2 x 89 89 - 100 
“The classification of pathology follows ELLENBOGEN et al. (1978) and BURKI et al. (1986) as described in Material 
and Methods section. 
bStandard errors refer to differences between results at the 2 dosage levels; no difference was significant (x2; 
P>O*O5). 
‘Percentage reduction at the months indicated; -=not examined. 
Months after treatment 
Fig. 1. Bladder pathology rafe following treatment with 40 mgkg 
(0) or 20 mgkg (-) of praziquantel. The line shows the exponential 
clearance (percentage reduction) fitted by regression analysis to the 
40 mg group. The vertical bars delimit the 95% confidence intervals 
of the 20 mg group and indicate the difference from the clearance in 
the 40 mg group. 
Fig. 2. Kidney pathology rate following treatment with 40 mgkg 
(0) or 20 mgikg (-) of praxiquantel. The line shows the exponential 
clearance (percentage reduction) fitted by regression analysis fo the 
40 mg group. The vertical bars delimit the 95% confidence intervals 
of the 20 mg group and indicate the difference from the clearance in 
the 40 mg group. 
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Months after treatmentC 
1 2 3 6 
31 5: 48 i; 
5.7 
Mild congestion 
Standard errorb 6.3 
Moderate congestion 
ii 2: 1-i 3; 
67 loo 
- 96 
Standard errorb 57.9 
Severe congestion 
2 
0 - - - 
2 50 
“The classification of pathology follows ELLENBOGEN et al. (1978) and BURKI et al. (1986) as described in Material 
and Methods section. 
bStandard errors refer to differences between results at the 2 dosage levels; no difference was significant (x2; 
P>O*O5). 
‘Percentage reduction at the months indicated; -=not examined. 
the 20 mg/kg group than in the 40 mg/kg group. 
There was no significant difference in clearance rates 
of the 20 mg and the 40 mg groups after 6 months. 
The detailed evolution of uropathy in the two groups 
is shown in Tables 3 and 4. 
Calcifications were demonstrated in 9 pupils (11%) 
at Milola school (40 mg/kg group). Clearance was 
complete in all 9 cases within 6 months. No calctica- 
tions were recorded among the children of Kibaoni 
school. 
Discussion 
This study indicates that in children recently 
infected with S. haematobium the related uropathy can 
improve greatly within 6 months after chemotherapy 
in an area of mild to moderate endemicity. Both 
bladder and kidney pathologies developed favourably 
after the 2 dosages of praxiquantel. Kidney congestion 
appeared to improve readily after resolution of the 
obstruction at bladder or ureter level. This may be 
due to the fact that we saw mainly mild congestive 
uropathy of possibly recent nature. Reversal is more 
likely with mild congestion than for chronic, more 
severe congestive pathology. Our findings contrast 
with the results of KING et al. (1988), who recorded 
delayed clearance of kidney pathology in coastal 
Kenya. This difference may have been due to 
longer-standing disease or to other factors related to 
transmission and host defence, bacterial superinfec- 
tion, or even to reinfections. Our own data (not 
shown) indicate that pathology due to reinfection can 
develop within 6-12 months after treatment with 
40 mgkg of praziquantel. 
Kidney pathology clearance tended to be slower in 
the first 3 months in the group that received 20 mg/kg 
of praxiquantel. However, the resolution of kidney 
congestion after six months, and the parasitological 
clearance rates, suggest comparable efficacies of 
20 mg/kg and 40 mg/kg of praziquantel. 
The 3 pupils with moderate congestive changes of 
the kidneys but no bladder pathology may have 
recently received antischistosomal therapy. However, 
it is also conceivable that bladder or ureter lesions 
were not detected in those cases. 
The low number of calcifications detected in the 
study groups may reflect the well-known deficiency of 
the ultrasound technique: fine lesions are frequently 
missed (BURKI et al., 1986). For technical reasons it 
was not possible to investigate a number of doubtful 
cases of calcified lesions by X-ray. Nine cases could be 
identified by their typical echo-dense structure with 
conical shadow. Two of them cleared within 2 
months, and the remaining 7 within 6 months, after 
treatment with 40 mg/kg of praxiquantel. This clear- 
ance contrasts with lindings of previous investigators 
(MACDONALD et al., 1%8), who saw no clearance of 
bladder calcifications. One factor explaining these 
observations may be the lower efficacy of the drugs 
used at that time. Spontaneous resolution of uropathy 
is often assumed to occur. It is likely that some of the 
pathology seen in our study groups would have 
cleared without treatment. The benign nature of 
many lesions suggests that this could be the case. 
We found that 20 mg/kg and 40 mg/kg of prazi- 
quantel showed comparable fficacy. The geometric 
mean egg output dropped in both groups to low 
numbers within one month, and the results were 
sustained up to 6 months (Table 1). The parasitologic- 
al clearance rates (Table 2) showed that heavy 
infections had a substantially lower response to either 
treatment han light infections. Although our study 
indicates comparable fficacy, larger trials are needed 
to con&m these findings. The design of these trials 
should also include randomization within villages or 
areas, to overcome possible bias due to individuals in 
an area with more severe pathology tending to be 
given higher doses, as might have been the case with 
the present design. 
The parasitological clearance rates in our study 
were higher than those recorded in previous studies 
(TAYLOR et al., 1988; WILKINS & MOORE, 1987). 
This may have been due to the lower egg output of 
our subjects. It also suggests the possibility of 
geographical differences, which have to be considered 
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for every schistosomiasis control project. Besides 
possible problems of development of resistance of the 
scbistosomes to praxiquantel, and the extreme care 
that must be taken when administering praxiquantel 
in an area where cysticercosis is present (not the caSe 
in our district), operational and economic considera- 
tions must be taken into account before deciding on a 
treatment policy in an endemic setting. 
The use of ultrasonography to detect lesions related 
to S. huemutobium infection is well established (KING 
et al., 1988). Ultrasound is the least invasive method 
to assess morbidity and clinical importance in popula- 
tions of endemic areas. Hence it can be used for 
decision making concerning public health measures 
and to monitor control programmes in progress 
(TANNER, 1989). In addition to laboratory and 
socio-economic parameters to monitor S. huemato- 
bium control projects, ultrasound should be used on a 
representative sample of the population covered by 
such projects. Following the conceptual change in 
schistosomiasis control from the control of transmis- 
sion to the reduction of morbidity, the issues of 
treatment and retreatment strategies are key elements 
and require a number of comparative studies on the 
evolution of schistosome-related morbidity in various 
endemic settings. 
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